Tower Wealth Partners’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$544K Sell
4,524
-2,291
-34% -$264K 0.3% 38
2025
Q4
$717K Buy
6,815
+935
+16% +$87.8K 0.39% 30
2025
Q3
$493K Buy
5,880
+255
+5% +$21K 0.27% 43
2025
Q2
$445K Buy
5,625
+943
+20% +$75K 0.26% 43
2025
Q1
$420K Sell
4,682
-935
-17% -$87.3K 0.22% 47
2024
Q4
$559K Sell
5,617
-688
-11% -$70.9K 0.29% 29
2024
Q3
$716K Sell
6,305
-1,577
-20% -$187K 0.42% 24
2024
Q2
$976K Buy
7,882
+1,678
+27% +$216K 0.6% 22
2024
Q1
$819K Sell
6,204
-383
-6% -$47.2K 0.53% 24
2023
Q4
$718K Sell
6,587
-740
-10% -$76.8K 0.51% 23
2023
Q3
$754K Buy
7,327
+16
+0.2% +$1.73K 0.62% 21
2023
Q2
$844K Buy
7,311
+1,139
+18% +$129K 0.68% 21
2023
Q1
$657K Sell
6,172
-1,463
-19% -$158K 0.55% 22
2022
Q4
$847K Buy
7,635
+235
+3% +$24K 0.74% 20
2022
Q3
$749K Buy
7,400
+1,213
+20% +$108K 0.71% 19
2022
Q2
$564K Buy
6,187
+1,359
+28% +$120K 0.75% 20
2022
Q1
$396K Buy
4,828
+1,414
+41% +$111K 0.43% 31
2021
Q4
$262K Sell
3,414
-997
-23% -$79.4K 0.27% 41
2021
Q3
$331K Buy
4,411
+1,349
+44% +$103K 0.35% 35
2021
Q2
$238K Sell
3,062
-140
-4% -$10.4K 0.26% 44
2021
Q1
$236K Buy
3,202
+7
+0.2% +$516 0.3% 46
2020
Q4
$249K Buy
+3,195
New +$244K 0.29% 35

Other funds holding MRK

Tower Wealth Partners's MRK Position: Q1 2026 in Review

Tower Wealth Partners reduced its Merck (MRK) stake by 34% in Q1 2026, selling an estimated $264K and leaving 4,524 shares worth $544K. The position accounts for 0.3% of the portfolio, ranked #38.

Tower Wealth Partners first reported a position in MRK in Q4 2020 and has held it in 22 quarters since. The position peaked at $976K in Q2 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Tower Wealth Partners held 4,524 shares of Merck worth $544K as of Q1 2026.
  • Tower Wealth Partners sold 2,291 Merck shares in Q1 2026, an estimated $264K.
  • Merck made up 0.3% of Tower Wealth Partners's portfolio in Q1 2026, its #38 holding.
  • Tower Wealth Partners first reported a position in Merck in Q4 2020 and has held it in 22 quarters since.
  • Tower Wealth Partners's Merck position peaked at $976K in Q2 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Tower Wealth Partners's 13F filing for Q1 2026, filed 8 May 2026.